The results of network pharmacology confirm that Qing Guang An Granule regulates p53, HIF-1, PI3K-Akt, and neurotrophin signaling pathways to treat glaucoma, which is similar to our results [32]. The gene discussed is AKT1; the disease is glaucoma.